News

NIPER Guwahati, Hindustan Antibiotics sign MoU for large scale manufacturing and commercialization of 3D antimicrobial face-shields

NIPER-Guwahati has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields.

Jun 09, 2020

By : Team ABLE

New EUbOPEN consortium launched; to provide chemical modulator tools to study disease biology

This large consortium has 65.8 million Euros orRs 565 crore commitment from 22 players.

Jun 09, 2020

By : Team ABLE

CSIR’s plant-based anti-cancer drug IIIM-290 enters clinical trial

The proposed clinical trial is aimed to assess the safety, tolerability and exposure of the compound in humans along with the early efficacy indicators in pancreatic cancer patients.

Jun 09, 2020

By : Team ABLE

A2A Pharmaceuticals collaborates LAXAI Life Sciences to co-develop SARS-CoV-2 Proteases Inhibitors

Both companies will collaborate in preclinical optimization and selection of lead candidates to enter the clinic.

Jun 09, 2020

By : Team ABLE

India, Australia invite research proposals for COVID-19

The research proposals are expected to focus on antiviral coatings, other preventive technologies, data analytics, modelling, AI applications, and screening and diagnostic testing as priority areas.

Jun 08, 2020

By : Team ABLE